Biocon Biologics secures US Market entry date for Bmab 1200
Biocon Biologics has signed a settlement and license agreement with Janssen Biotech Inc., and Johnson & Johnson (collectively known as Janssen) that clears the way to commercialize its Bmab 1200,…
Lire la suite / Read more